ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 98 filers reported holding ALDEYRA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $460,000 | +77.6% | 62,100 | 0.0% | 0.09% | +61.8% |
| Q2 2020 | $259,000 | +181.5% | 62,100 | +67.4% | 0.06% | +52.8% |
| Q1 2020 | $92,000 | -57.4% | 37,100 | 0.0% | 0.04% | +5.9% |
| Q4 2019 | $216,000 | -12.9% | 37,100 | -21.2% | 0.03% | -39.3% |
| Q3 2019 | $248,000 | -12.1% | 47,100 | 0.0% | 0.06% | +27.3% |
| Q2 2019 | $282,000 | -40.0% | 47,100 | -9.6% | 0.04% | -51.1% |
| Q1 2019 | $470,000 | +8.8% | 52,100 | 0.0% | 0.09% | -17.4% |
| Q4 2018 | $432,000 | -43.1% | 52,100 | -5.3% | 0.11% | +6.9% |
| Q3 2018 | $759,000 | +112.0% | 55,000 | +22.2% | 0.10% | +88.9% |
| Q2 2018 | $358,000 | +6.5% | 45,000 | 0.0% | 0.05% | +8.0% |
| Q1 2018 | $336,000 | +9.8% | 45,000 | 0.0% | 0.05% | +35.1% |
| Q4 2017 | $306,000 | +7.4% | 45,000 | +13.8% | 0.04% | -2.6% |
| Q3 2017 | $285,000 | +109.6% | 39,552 | +35.9% | 0.04% | +245.5% |
| Q2 2017 | $136,000 | – | 29,104 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 1,009,131 | $7,568,000 | 1.15% |
| Knoll Capital Management, LLC | 124,096 | $931,000 | 0.96% |
| 683 Capital Management, LLC | 1,000,000 | $7,500,000 | 0.66% |
| Perceptive Advisors | 3,085,458 | $23,141,000 | 0.65% |
| MANGROVE PARTNERS IM, LLC | 324,019 | $2,430,000 | 0.16% |
| Stanley-Laman Group, Ltd. | 64,029 | $480,000 | 0.11% |
| WOODSTOCK CORP | 67,759 | $508,000 | 0.10% |
| Hikari Power Ltd | 107,858 | $809,000 | 0.10% |
| ARDSLEY ADVISORY PARTNERS LP | 45,000 | $336,000 | 0.05% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 750,000 | $5,625,000 | 0.01% |